课题基金 / 基金详情

MOLECULAR CHANGES IN ANTIBODY AFFINITY IN THE ELDERLY

MOLECULAR CHANGES IN ANTIBODY AFFINITY IN THE ELDERLY
老年人抗体亲和力的分子变化
批准号:
2330217
负责人:
URI GALILI GALILI
金额:
$22.97万
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-02-20 至 1999-01-31

项目摘要

项目成果

URI GALILI GALILI的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Adapted from the Applicant's Abstract): The objective of this proposal is to study the molecular basis for the decreased ability of the immune system in many elderly individuals, to produce high affinity antibodies and thus mount an effective immune response to vaccines or infections. To pursue this objective, the principal investigator will study the age-associated changes in the relationship between structure and function of immunoglobulin VH and VL genes which produce the natural anti-Gal antibody. Anti-Gal constitutes 1% of circulating IgG in humans and interacts specifically with the carbohydrate structure Gala1-3GalB1-4GlcNAc-R (termed alpha-galactosyl epitope). As many as 1% of circulating B lymphocytes can produce anti- Gal. The applicant has found that most of the sequenced VH genes in anti-Gal producing lymphoid clones, cluster within a distinct region of the VH3 immunoglobulin gene family, and that these genes undergo somatic mutations. Analysis of age-associated changes in activity of anti-Gal have demonstrated loss of affinity of this antibody in many elderly individuals. The principal investigator proposes to study two possible mechanisms which may cause the age-associated impairment in anti-Gal affinity in humans: 1) different utilization of VH and VL genes repertoire for anti-Gal synthesis; and 2) impaired affinity maturation in anti-Gal genes because of age-associated changes in the somatic mutations process. For this purpose he will construct combinatorial phage display libraries in young and in elderly individuals and isolate the anti-Gal displaying phage. Comparative analysis of the anti-Gal VH and VL gene repertoire in the young and elderly, and determination of the resulting antibody affinities, will enable the applicant to establish whether the age-associated decrease in antibody affinity correlates with the gene repertoire used for anti-Gal synthesis. Comparison of the V gene sequences with the corresponding germline genes will allow the investigators to establish whether the age-associated changes reflect the excess or paucity of somatic mutations in anti-Gal producing genes. The applicant will further determine whether elderly individuals with low affinity serum anti-Gal retain some high affinity clones, by selecting high affinity anti-Gal phage from the libraries of these individuals. Lastly, by correlating anti-Gal affinity with the immune response to an influenza virus vaccine, the principal investigator will determine whether anti-Gal can predict the competence of the immune system in elderly individuals to produce high affinity antibodies. Thus, by exploiting the anti-Gal system, the applicant aims to understand the molecular basis of the well-documented age-associated impairment of humoral immune responses in humans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Intratumoral Injection of a-gal Glycolipids in Stage IV Melanoma: Phase I Trial
Intratumoral injection of a-gal glycolipids in stage IV melanoma: Phase I Trial
Xenograft-like rejection of tumors in a-gal glycolipids
Xenograft-like rejection of tumors in a-gal glycolipids
海外基金